Fig. 3From: Conversion surgery for advanced hepatocellular carcinoma after combination treatment of lenvatinib and camrelizumab: a case reportThe preoperative change of the patient’s peripheral blood lymphocyte subgroups from October 10, 2020, to April 14, 2021. Tc, cytotoxic T cell; Ts, suppressor T cell; Th, helper T cellBack to article page